Battaglini Claudio L, Hackney A C, Garcia Rey, Groff Diane, Evans Elizabeth, Shea Thomas
Lineberger Comprehensive Cancer Center, Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, North Carolina 27599, USA.
Integr Cancer Ther. 2009 Jun;8(2):130-8. doi: 10.1177/1534735409334266.
To examine the feasibility of administering an in-hospital exercise program to acute leukemia patients undergoing chemotherapy. A secondary purpose explored the impact of exercise on selected physiological, psychological, and inflammatory markers.
Ten patients, aged 18 to 50 years, diagnosed with acute leukemia or newly relapsed were assessed for body weight, height, body composition (skinfolds), cardiorespiratory endurance (total minutes on bicycle ergometer at 60% heart rate reserve), dynamic muscular endurance (Rocky Mountain Cancer Rehabilitation Institute protocol), fatigue (Revised Piper Fatigue Scale), depression (Center for Epidemiologic Studies Depression scale, National Institute of Mental Health questionnaire), and quality of life (Functional Assessment of Cancer Therapy-General) at baseline (within 3 days of diagnosis) and at the end of induction phase of treatment. Blood draws were taken at baseline, midpoint, and at the end of induction for analyses of inflammatory markers (Linco Luminex assay). Combined aerobic and strength training exercises were administered 3 times per week, twice daily, for 30 minutes. Paired-samples t-tests were used for the analyses of physiological and psychological parameters. One-way repeated measures analysis of variance was used for the analyses of inflammatory markers.
Significant improvements in cardiorespiratory endurance (P = .009, baseline 8.9 +/- 8.8 minutes, postexercise intervention 17 +/- 14.3 minutes) with significant reductions in total fatigue scores (P = .009, baseline 4.6 +/- 1.7, postexercise intervention 1.8 +/- 1.6) and depression scores (P = .023, baseline 19 +/- 11.5, postexercise intervention 12 +/- 8.2) were observed. Marginally significant decrease in interleukin-6 (IL-6; P = .059) with no significant changes in IL-10 (P = .223) or interferon-gamma (P = .882) were observed.
Administration of exercise to acute leukemia patients undergoing treatment is feasible. The exercise protocol used increased cardiovascular endurance, reduced fatigue and depression scores, and maintained quality of life. Although no significant change in inflammation was observed, a trend demonstrating a reduction in IL-6 and an increase in IL-10 warrants further investigation.
探讨对接受化疗的急性白血病患者实施院内运动计划的可行性。第二个目的是探究运动对选定的生理、心理和炎症标志物的影响。
对10名年龄在18至50岁、被诊断为急性白血病或新复发的患者,在基线期(诊断后3天内)和治疗诱导期结束时评估体重、身高、身体成分(皮褶厚度)、心肺耐力(在心率储备60%的情况下在自行车测力计上的总时长)、动态肌肉耐力(落基山癌症康复研究所方案)、疲劳(修订版派珀疲劳量表)、抑郁(流行病学研究中心抑郁量表,美国国立精神卫生研究所问卷)和生活质量(癌症治疗功能评估通用版)。在基线期、中期和诱导期结束时采集血样,用于分析炎症标志物(Linco Luminex检测法)。每周进行3次有氧和力量训练组合运动,每天2次,每次30分钟。采用配对样本t检验分析生理和心理参数。采用单因素重复测量方差分析炎症标志物。
观察到心肺耐力有显著改善(P = 0.009,基线期8.9±8.8分钟,运动干预后17±14.3分钟),总疲劳评分显著降低(P = 0.009,基线期4.6±1.7,运动干预后1.8±1.6),抑郁评分显著降低(P = 0.023,基线期19±11.5,运动干预后12±8.2)。观察到白细胞介素-6(IL-6)有轻微显著下降(P = 0.059),而IL-10(P = 0.223)或干扰素-γ(P = 0.882)无显著变化。
对接受治疗的急性白血病患者进行运动干预是可行的。所采用的运动方案提高了心血管耐力,降低了疲劳和抑郁评分,并维持了生活质量。尽管未观察到炎症有显著变化,但白细胞介素-6降低和白细胞介素-10升高的趋势值得进一步研究。